- Net sales in 2013: EUR 2,526 million
- Headquarters: Whippany, New Jersey (USA)
In the Medical Care Division we offer blood glucose monitoring devices such as the single-strip Contour™ system and the multi-strip Breeze™ system. We also market the Contour™ USB meter, which features integrated diabetes management software and direct plug-in to computers. Outside Europe, these products are generally sold to consumers through pharmacies, drugstores, mass merchants, hospitals or wholesalers. In Europe, they are sold mainly through pharmacies.
As well as being among the top companies in the market for blood glucose monitoring devices, we are the world’s leading supplier of contrast agent injection systems for diagnostic and therapeutic medical procedures in computed tomography, magnetic resonance imaging and molecular imaging, and of mechanical systems for removing thrombi from blood vessels. We also offer service products for these systems. To strengthen our position among the leading companies in the field of innovative, high-quality diagnostic imaging and interventional procedures, we have combined our diagnostic imaging business, formerly part of the Pharmaceuticals segment, and our medical equipment business to form a new Radiology and Interventional business unit. Examples from our portfolio of contrast agents used in diagnostic imaging are Ultravist™, Magnevist™ and Gadovist™/ Gadavist™. Our products are marketed to cardiologists, radiologists and vascular surgeons in hospitals and out-patient clinical sites through a global direct sales organization, supplemented in some cases by local distributors.